{"transactions":[{"id":372,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-02T20:06:56.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":644,"price":9.7,"value":6246.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $12,500."}],"balance_after":47821,"source":{"system":"sec-edgar","filing":"0000882796-26-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1883764/000088279626000059/form4.xml","form_type":"4"}},{"id":738594,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2026-06-15T20:08:27.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":33540,"derivative":{"exercise_price":8.5,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":33540},"source":{"system":"sec-edgar","filing":"0000882796-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000037/form4.xml","form_type":"4"}},{"id":738593,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-15T20:08:27.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":47177,"source":{"system":"sec-edgar","filing":"0000882796-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000037/form4.xml","form_type":"4"}},{"id":756035,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-02T20:11:14.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":631,"price":8.91,"value":5622.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":31883,"source":{"system":"sec-edgar","filing":"0000882796-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000029/form4.xml","form_type":"4"}},{"id":773422,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-19T20:07:43.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":11180,"price":8.97,"value":100284.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.96 to $8.985. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":31252,"source":{"system":"sec-edgar","filing":"0000882796-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000023/form4.xml","form_type":"4"}},{"id":871215,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-03T21:25:59.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":642,"price":8.75,"value":5617.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":42432,"source":{"system":"sec-edgar","filing":"0000882796-26-000005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279626000005/form4.xml","form_type":"4"}},{"id":984289,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-02T21:14:11.000Z","date":"2025-11-28","kind":"grant","planned":false,"acquired":true,"shares":783,"price":7.18,"value":5621.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":41790,"source":{"system":"sec-edgar","filing":"0000882796-25-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000023/form4.xml","form_type":"4"}},{"id":1050644,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-09-03T20:30:01.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":676,"price":8.31,"value":5617.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250."}],"balance_after":41007,"source":{"system":"sec-edgar","filing":"0000882796-25-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000013/form4.xml","form_type":"4"}},{"id":1110480,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Automatic Stock Option Grant","published_at":"2025-06-16T20:21:36.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":27181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":27181,"derivative":{"exercise_price":10.4,"exercise_date":"2026-06-12","expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":27181},"source":{"system":"sec-edgar","filing":"0001171843-25-003916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003916/ownership.xml","form_type":"4"}},{"id":1110479,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:21:36.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":40331,"source":{"system":"sec-edgar","filing":"0001171843-25-003916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003916/ownership.xml","form_type":"4"}},{"id":1469975,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-25T20:39:56.000Z","date":"2024-06-24","kind":"sale","planned":false,"acquired":false,"shares":8600,"price":6.32,"value":54352.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold with the sole purpose of generating sufficient proceeds to cover the tax liability incurred in connection with the vesting of 16,745 Restricted Stock Units on June 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.25 to $6.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":27831,"source":{"system":"sec-edgar","filing":"0001127602-24-019215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224019215/form4.xml","form_type":"4"}},{"id":1479833,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2024-06-14T20:30:11.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":49933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":49933,"derivative":{"exercise_price":6.3,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":49933},"source":{"system":"sec-edgar","filing":"0001127602-24-018728","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224018728/form4.xml","form_type":"4"}},{"id":1479832,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-14T20:30:11.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":36431,"source":{"system":"sec-edgar","filing":"0001127602-24-018728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224018728/form4.xml","form_type":"4"}},{"id":1855056,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2023-06-15T20:31:25.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":39072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":39072,"derivative":{"exercise_price":8.18,"exercise_date":"2024-06-13","expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":39072},"source":{"system":"sec-edgar","filing":"0001127602-23-018771","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223018771/form4.xml","form_type":"4"}},{"id":1855055,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-15T20:31:25.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":16745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":29611,"source":{"system":"sec-edgar","filing":"0001127602-23-018771","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223018771/form4.xml","form_type":"4"}},{"id":2238283,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2022-06-09T20:46:27.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":30022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":30022,"derivative":{"exercise_price":10.79,"exercise_date":"2023-06-07","expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":30022},"source":{"system":"sec-edgar","filing":"0001127602-22-017160","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222017160/form4.xml","form_type":"4"}},{"id":2238282,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-09T20:46:27.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":12866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":12866,"source":{"system":"sec-edgar","filing":"0001127602-22-017160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222017160/form4.xml","form_type":"4"}},{"id":2562461,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":358,"kind":"person","name":"McKee Amy E","position":1,"cik":"0001883764","reported_name":"McKee Amy E","relationship":{"director":true}}],"security":"Non-Qualified Stock Option","published_at":"2021-09-22T20:15:41.000Z","date":"2021-09-20","kind":"grant","acquired":true,"shares":53333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 1/36 per month for a period of 36 months, beginning on October 20, 2021"}],"balance_after":53333,"derivative":{"exercise_price":15.02,"expiration_date":"2031-09-20","underlying":"Common Stock","underlying_shares":53333},"source":{"system":"sec-edgar","filing":"0001127602-21-025686","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221025686/form4.xml","form_type":"4"}}]}